Alps Advisors Inc Applied Molecular Transport Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.76 - $7.65 $109,654 - $303,934	-39,730 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.63 - $13.88 $27,102 - $66,818	-4,814 Reduced 10.81%	39,730 $299,000
Q4 2021 Feb 09, 2022	SELL	$13.23 - $26.05 $33,723 - $66,401	-2,549 Reduced 5.41%	44,544 $623,000
Q3 2021 Nov 15, 2021	SELL	$25.87 - $46.61 $86,043 - $155,024	-3,326 Reduced 6.6%	47,093 $1.22 Million
Q2 2021 Aug 11, 2021	BUY	$39.76 - $64.31 $2 Million - $3.24 Million	50,419 New	50,419 $2.31 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.